State-of-the-art behavioral and pharmacological treatments for alcohol use disorder
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Alcohol use disorder (AUD) and its associated consequences remain significant public health concerns. Given that AUD represents a spectrum of severity, treatment options represent a continuum of care, ranging from single-session brief interventions to more intensive, prolonged, and specialized treatment modalities. OBJECTIVE: This qualitative literature review seeks to describe the best practices for AUD by placing a particular emphasis on identifying those practices which have received the most empirical support. METHOD: This review summarizes psychological and pharmacological intervention options for AUD treatment, with a focus on the relapse prevention phase of recovery. Psychological and pharmacological treatments are summarized in terms of the empirical evidence favoring each approach and the level of AUD severity for which they are most indicated. SCIENTIFIC SIGNIFICANCE: One of the broad assertions from this review is that while AUD is highly prevalent, seeking treatment for AUD is not. There are a myriad of behavioral and pharmacological treatments that have shown compelling evidence of efficacy for the treatment of AUD. In the behavioral treatment literature, cognitive behavioral therapy has received the most consistent support. Opioid antagonism (via naltrexone) has been the most widely studied pharmacotherapy and has produced moderate effect sizes. While none of the treatments reviewed herein represents a so-called silver bullet for AUD, they each have the potential to significantly improve the odds of recovery. Precision medicine, or the identification of best treatment matches for individual patients, looms as an important overarching goal for the field, although specific matches are not yet sufficiently reliable in their empirical evidence to warrant clinical dissemination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses
Hofmann, S. G., Asnaani, A., Vonk, I. J. J., Sawyer, A. T., & Fang, A. (2012) · Cognitive Therapy and Research · doi:10.1007/s10608-012-9476-1 · Cited by 3,445 · cited 1×
“be more effective for women than men (37).”
BackgroundHasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.830 · Cited by 2,908
Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0584 · Cited by 2,556
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Effectiveness of brief alcohol interventions in primary care populations
Kaner, E. F., Beyer, F. R., Muirhead, C., Campbell, F., Pienaar, E. D., Bertholet, N., Daeppen, J. B., Saunders, J. B., & Burnand, B. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004148.pub4 · Cited by 1,665
Seedat, S., Scott, K. M., Angermeyer, M. C., Berglund, P., Bromet, E. J., Brugha, T. S., Demyttenaere, K., de Girolamo, G., Haro, J. M., Jin, R., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.36 · Cited by 1,518
Is there a common molecular pathway for addiction?
Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388
Grant, B. F., Chou, S. P., Saha, T. D., Pickering, R. P., Kerridge, B. T., Ruan, W. J., Huang, B., Jung, J., Zhang, H., Fan, A., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.2161 · Cited by 1,362
A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287
2010 National and State Costs of Excessive Alcohol Consumption
Sacks, J. J., Gonzales, K. R., Bouchery, E. E., Tomedi, L. E., & Brewer, R. D. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.05.031 · Cited by 1,180 · cited 1×
“that the economic burden of AUD treatment is $250 billion nationally (8).”
BackgroundMoyer, A., Finney, J. W., Swearingen, C. E., & Vergun, P. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00018.x · Cited by 1,092 · cited 1×
“treatment plans for those seeking treatment or for individuals with recurrent, moderate-to-severe AUD (25,27).”
BackgroundJonas, D. E., Amick, H. R., Feltner, C., Bobashev, G., Thomas, K., Wines, R., Kim, M. M., Shanahan, E., Gass, C. E., Rowe, C. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.3628 · Cited by 923
Bertholet, N. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.9.986 · Cited by 710
Bowen, S., Witkiewitz, K., Clifasefi, S. L., Grow, J., Chawla, N., Hsu, S. H., Carroll, H. A., Harrop, E., Collins, S. E., Lustyk, M. K., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4546 · Cited by 701
Magill, M., & Ray, L. A. (2009) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2009.70.516 · Cited by 694 · cited 1×
“dies, reviews, and meta-analyses corroborate the efficacy of CBT for treating AUD (33–35), although there are larger effect sizes for other substances of abuse compared to alcohol (34,36).”
BackgroundSelf-citationCognitive Behavioral Therapy for Substance Use Disorders
McHugh, R. K., Hearon, B. A., & Otto, M. W. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.04.012 · Cited by 626
Naltrexone in the Treatment of Alcohol Dependence
Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F., & Rosenheck, R. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011127 · Cited by 618
Topiramate for Treating Alcohol Dependence<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
Johnson, B. A. (2007) · JAMA · doi:10.1001/jama.298.14.1641 · Cited by 542
Mindfulness-based relapse prevention for alcohol and substance use disorders
Witkiewitz, K., Marlatt, G. A., & Walker, D. (2005) · Journal of Cognitive Psychotherapy · doi:10.1891/jcop.2005.19.3.211 · Cited by 514
Anton, R. F., Oroszi, G., O’Malley, S., Couper, D., Swift, R., Pettinati, H., & Goldman, D. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.2.135 · Cited by 451
Mindfulness treatment for substance misuse: A systematic review and meta-analysis
Li, W., Howard, M. O., Garland, E. L., McGovern, P., & Lazar, M. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.01.008 · Cited by 446
Pharmacological Treatment of Alcohol Dependence: A Review of the Evidence
Garbutt, J. C., West, S. L., Carey, T. S., Lohr, K. N., & Crews, F. T. (1999) · JAMA · doi:10.1001/jama.281.14.1318 · Cited by 444 · cited 1×
“Disulfiram has demonstrated mixed clinical efficacy, largely due to poor adherence (111,112); however, a recent metaanalysis reported a significant effect of disulfiram in”
BackgroundJonas, D. E., Garbutt, J. C., Amick, H. R., Brown, J. M., Brownley, K. A., Council, C. L., Viera, A. J., Wilkins, T. M., Schwartz, C. J., Richmond, E. M., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-9-201211060-00544 · Cited by 387
Gabapentin misuse, abuse and diversion: A systematic review
Smith, R. V., Havens, J. R., & Walsh, S. L. (2016) · Addiction · doi:10.1111/add.13324 · Cited by 378
Tonigan, J. S., Toscova, R., & Miller, W. R. (1996) · Journal of Studies on Alcohol · doi:10.15288/jsa.1996.57.65 · Cited by 350
Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis
Skinner, M. D., Lahmek, P., Pham, H., & Aubin, H.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087366 · Cited by 347
Alcoholics Anonymous and other 12-step programmes for alcohol dependence
Ferri, M., Amato, L., & Davoli, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005032.pub2 · Cited by 347
Gabapentin Treatment for Alcohol Dependence: A Randomized Clinical Trial
Mason, B. J., Quello, S., Goodell, V., Shadan, F., Kyle, M., & Begovic, A. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.11950 · Cited by 340
Mindfulness-Based Relapse Prevention for substance craving
Witkiewitz, K., Bowen, S., Douglas, H., & Hsu, S. H. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.04.001 · Cited by 337
Heterogeneity of Alcohol Use Disorder: Understanding Mechanisms to Advance Personalized Treatment
Litten, R. Z., Ryan, M. L., Falk, D. E., Reilly, M., Fertig, J. B., & Koob, G. F. (2015) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12669 · Cited by 330
Online Alcohol Interventions: A Systematic Review
White, A., Kavanagh, D., Stallman, H., Klein, B., Kay-Lambkin, F., Proudfoot, J., Drennan, J., Connor, J., Baker, A., Hines, E., et al. (2010) · Journal of Medical Internet Research · doi:10.2196/jmir.1479 · Cited by 305
Behavioral couples therapy (BCT) for alcohol and drug use disorders: A meta-analysis
Powers, M. B., Vedel, E., & Emmelkamp, P. M. G. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2008.02.002 · Cited by 300 · cited 1×
“and improving treatment retention for married and cohabitating individuals with AUD (38,39).”
BackgroundLitten, R. Z., Ryan, M. L., Fertig, J. B., Falk, D. E., Johnson, B., Dunn, K. E., Green, A. I., Pettinati, H. M., Ciraulo, D. A., Sarid-Segal, O., et al. (2013) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31829623f4 · Cited by 287 · cited 1×
“examined as part of the NCIG initiative (127) and found to significantly reduce weekly percent heavy drinking days, drinks per day, drinks per drinking”
BackgroundRiper, H., Andersson, G., Hunter, S. B., Wit, J., Berking, M., & Cuijpers, P. (2014) · Addiction · doi:10.1111/add.12441 · Cited by 276 · cited 2×
“and depression among individuals with comorbid AUD and major depression (28).”
BackgroundRay, L. A., & Hutchison, K. E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1069 · Cited by 258 · cited 1×
“one that have generally demonstrated that naltrexone reduces the subjective pleasurable effects of alcohol (88,89), craving for alcohol (90,91), drinks per drinking”
BackgroundSelf-citationSAITZ, R. (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2010.00217.x · Cited by 241 · cited 1×
“treatment plans for those seeking treatment or for individuals with recurrent, moderate-to-severe AUD (25,27).”
BackgroundMitchell, J. M., O’Neil, J. P., Janabi, M., Marks, S. M., Jagust, W. J., & Fields, H. L. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002902 · Cited by 237 · cited 2×
“tributing to the pleasurable effects of alcohol (84,85), thus an opioid antagonist is proposed to block these”
BackgroundBewick, B. M., Trusler, K., Barkham, M., Hill, A. J., Cahill, J., & Mulhern, B. (2008) · Preventive Medicine · doi:10.1016/j.ypmed.2008.01.005 · Cited by 233 · cited 1×
“Initial evidence indicates that technology-based interventions have promise to treat individuals with a lower severity of alcohol problems (69,70) and for individuals who”
BackgroundStreeton, C. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.6.544 · Cited by 228
Effects of cue-exposure treatment on neural cue reactivity in alcohol dependence: a randomized trial
Vollstädt-Klein, S., Loeber, S., Kirsch, M., Bach, P., Richter, A., Bühler, M., von der Goltz, C., Hermann, D., Mann, K., & Kiefer, F. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.016 · Cited by 202 · cited 1×
“(48,49), in conjunction with pharmacotherapies (50), and in fMRI work (51).”
BackgroundScott-Sheldon, L. A. J., Carey, K. B., Elliott, J. C., Garey, L., & Carey, M. P. (2014) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0035192 · Cited by 198
Does disulfiram have a role in alcoholism treatment today?
FULLER, R. K., & GORDIS, E. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00597.x · Cited by 182 · cited 1×
“attaining sobriety (114); however, compliance and medical management (MM) issues, including the risk for severe medical complications when the medication is”
BackgroundD'Onofrio, G., & Degutis, L. C. (2002) · Academic Emergency Medicine · doi:10.1197/aemj.9.6.627 · Cited by 178
The COMBINE Study Research Group (2003) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2003.tb02873.x · Cited by 174
Cue exposure therapy for the treatment of alcohol use disorders: a meta-analytic review
Mellentin, A. I., Skøt, L., Nielsen, B., Schippers, G. M., Nielsen, A. S., Stenager, E., & Juhl, C. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.07.006 · Cited by 149
Using e-technologies in clinical trials
Rosa, C., Campbell, A. N. C., Miele, G. M., Brunner, M., & Winstanley, E. L. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.07.007 · Cited by 147 · cited 1×
“Initial evidence indicates that technology-based interventions have promise to treat individuals with a lower severity of alcohol problems (69,70) and for individuals who”
BackgroundFurieri, F. A., & Nakamura-Palacios, E. M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1108 · Cited by 144 · cited 1×
“to reduce drinking outcomes (135,136), and in combi-”
BackgroundDrobes, D. J., Anton, R. F., Thomas, S. E., & Voronin, K. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000139704.88862.01 · Cited by 140
Schmidt, C. S., Schulte, B., Seo, H., Kuhn, S., O'Donnell, A., Kriston, L., Verthein, U., & Reimer, J. (2016) · Addiction · doi:10.1111/add.13263 · Cited by 107 · cited 1×
“Several meta-analyses have supported the efficacy of MI and MET, particularly in emergency departments (30) and”
MethodIncreased NMDA-induced excitability during ethanol withdrawal: a behavioural and histological study
Davidson, M., Shanley, B., & Wilce, P. (1995) · Brain Research · doi:10.1016/0006-8993(94)01440-s · Cited by 94
for the National Institute on Alcohol Abuse and Alcoholism Clinical Investigations Group (NCIG) Study Group, Ryan, M. L., Falk, D. E., Fertig, J. B., Rendenbach-Mueller, B., Katz, D. A., Tracy, K. A., Strain, E. C., Dunn, K. E., Kampman, K., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.214 · Cited by 72
The role of the vasopressin 1b receptor in aggression and other social behaviours
CALDWELL, H., WERSINGER, S., & YOUNGIII, W. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00406-8 · Cited by 64
Brown, E. S., Davila, D., Nakamura, A., Carmody, T. J., Rush, A. J., Lo, A., Holmes, T., Adinoff, B., Caetano, R., Swann, A. C., et al. (2014) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12445 · Cited by 50
Using contingency management procedures to reduce at-risk drinking in heavy drinkers
Dougherty, D. M., Lake, S. L., Hill-Kapturczak, N., Liang, Y., Karns, T. E., Mullen, J., & Roache, J. D. (2015) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12687 · Cited by 45 · cited 1×
“Within alcohol users, CM has been found to be efficacious in reducing drinking in nontreatment-seeking heavy drinkers (45)”
Background
Cited by
Ray, L. A., Meredith, L. R., Kiluk, B. D., Walthers, J., Carroll, K. M., & Magill, M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8279 · Cited by 265
Self-citationNovel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Burnette, E. M., Nieto, S. J., Grodin, E. N., Meredith, L. R., Hurley, B., Miotto, K., Gillis, A. J., & Ray, L. A. (2022) · Drugs · doi:10.1007/s40265-021-01670-3 · Cited by 169
“These medications are only modestly effective [13] and are under-utilized in treatment.”
BackgroundSelf-citationGrodin, E. N., Nieto, S. J., Meredith, L. R., Burnette, E., O'Neill, J., Alger, J., London, E. D., Miotto, K., Evans, C. J., Irwin, M. R., et al. (2022) · Addiction Biology · doi:10.1111/adb.13182 · Cited by 25
Self-citationClinical neuroscience of addiction: what clinical psychologists need to know and why
Ray, L. A., & Grodin, E. N. (2021) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-081219-114309 · Cited by 18
Self-citation
Metadata
- Authors
- Ray, L. A., Bujarski, S., Grodin, E., Hartwell, E., Green, R., Venegas, A., Lim, A. C., Gillis, A., & Miotto, K.
- Venue
- The American Journal of Drug and Alcohol Abuse
- Publisher
- Informa UK Limited
- Published
- 2018-10-29
- Volume
- 45
- Issue
- 2
- Pages
- 124-140
- ISSN
- 0095-2990 (ISSN-L)
- 1097-9891
- OpenAlex
- W2898948647
- Cited by
- 137
- References
- 54
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.